ENZO BIOCHEM INC Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2024 1 months to Aug 31, 2024	FY2023 12 months to Jul 31, 2023	FY2022 12 months to Jul 31, 2022	FY2021 12 months to Jul 31, 2021	FY2020 12 months to Jul 31, 2020
Revenues
Operating costs, expenses and legal settlements, net:
Cost of revenues
Inventory Provision
Total cost of revenues
Cost of revenue – inventory provision
Research and development
Selling, general, and administrative
Legal and related expenses
Legal settlements
Total costs, expenses and legal settlements, net
Total costs and expenses, net
Operating loss
Other income (expense):
Interest
Interest income
Interest expense
Change in fair value of convertible debentures
Other
Foreign exchange gain (loss)
Foreign exchange (loss) gain
(Loss) income before income taxes

Loss before income taxes
Net loss from continuing operations
Net loss from discontinued operations
Gain on sale of discontinued operations, net of tax
Net (loss) income
Net (loss) income per common share – basic and diluted:
Continuing operations. basic (in Dollars per share)
Discontinued operations (in Dollars per share)
Continuing operations, diluted (in Dollars per share)
Discontinued operations, basic (in Dollars per share)
Discontinued operations, diluted (in Dollars per share)
Total net (loss) income per basic common share (in Dollars per share)
Total net income (loss) per diluted common share (in Dollars per share)
Weighted average common shares outstanding:
Basic (in Shares)
Diluted (in Shares)

Comments